IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $136,000 | +3300.0% | 23,314 | +689.8% | 0.00% | – |
Q4 2018 | $4,000 | -91.8% | 2,952 | -78.9% | 0.00% | – |
Q3 2018 | $49,000 | +308.3% | 13,999 | +467.2% | 0.00% | – |
Q2 2018 | $12,000 | -45.5% | 2,468 | -63.1% | 0.00% | – |
Q1 2018 | $22,000 | +10.0% | 6,685 | +31.5% | 0.00% | – |
Q4 2017 | $20,000 | -84.3% | 5,083 | -58.7% | 0.00% | – |
Q3 2017 | $127,000 | – | 12,296 | +102366.7% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 12 | -97.8% | 0.00% | – |
Q1 2017 | $3,000 | -94.1% | 546 | -94.0% | 0.00% | – |
Q4 2016 | $51,000 | +5000.0% | 9,158 | +5287.1% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 170 | -35.6% | 0.00% | – |
Q2 2016 | $2,000 | +100.0% | 264 | +288.2% | 0.00% | – |
Q1 2016 | $1,000 | -83.3% | 68 | -78.3% | 0.00% | – |
Q4 2015 | $6,000 | +500.0% | 314 | +423.3% | 0.00% | – |
Q3 2015 | $1,000 | -75.0% | 60 | -72.1% | 0.00% | – |
Q2 2015 | $4,000 | 0.0% | 215 | +17.5% | 0.00% | – |
Q1 2015 | $4,000 | -63.6% | 183 | -47.3% | 0.00% | – |
Q4 2014 | $11,000 | – | 347 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,236,394 | $4,080,000 | 4.69% |
Versant Venture Management, LLC | 2,208,210 | $7,287,093,000 | 2.33% |
EcoR1 Capital, LLC | 4,437,600 | $14,422,000 | 1.45% |
BVF INC/IL | 4,106,200 | $13,550,000 | 1.37% |
Abingworth LLP | 352,300 | $1,145,000 | 0.71% |
DAFNA Capital Management LLC | 328,500 | $1,084,000 | 0.53% |
Bain Capital Public Equity Management, LLC | 1,680,987 | $5,547,000 | 0.40% |
Telemetry Investments, L.L.C. | 248,800 | $821,000 | 0.31% |
Stonepine Capital Management, LLC | 161,226 | $532,000 | 0.28% |
Focused Wealth Management, Inc | 12,395 | $41,000 | 0.01% |